LXRX
Lexicon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.24
−0.88%Leverage
- Debt / equity
- 0.34x
- Net debt / equity
- 0.11x
- Debt / assets
- 0.24x
- Debt / EBITDA
- -1.13x
- Net debt / EBITDA
- -0.35x
Liquidity & coverage
- Current ratio
- 13.37x
- Quick ratio
- 13.29x
- Cash ratio
- 12.96x
- Interest coverage
- -6.50x
- EBITDA / interest
- -6.23x
- Working capital
- $181.9M
Cash & dividend
- FCF / debt
- -1.34x
- Cash flow / debt
- -1.34x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026